Select language:  
1800 620 420
Close menu

More Australians with blood cancer reliant on blood donations than ever before

  • Media releases
  • Research
Read more
Illustration of a mobile phone flashing 'News' on the screen

National report confirms incidence of blood cancer continues to rise in Australia

  • Media releases
  • Research
Read more
Illustration of a mobile phone flashing 'News' on the screen

International precision medicine clinical trials recruiting

Two new international clinical trials are expected to improve access to new therapies for Australians with MDS as part of the Leukaemia Foundation’s Trials Enabling Program (TEP).

  • Clinical trials
  • Myelodysplastic syndromes
  • Research
Read more
AMLM23 Principal Investigator, Professor Paula Marlton

Improving infection prevention with drug optimisation

Julian Lindsay’s goal is to set up an international study aimed at improving survival and quality of life through drug optimisation.

  • Hodgkin lymphoma
  • Non-Hodgkin lymphoma
  • Research
  • Treatments and side-effects
Read more
Dr Julian Lindsay

Study examines COVID-19 vaccine response in low-grade lymphoma

An Australian study will examine the immune response to the COVID-19 vaccine in patients with the low-grade non-Hodgkin lymphomas.

  • Non-Hodgkin lymphoma
  • Research
Read more
Concord research group

Expert Series: AProf. Michael Dickinson discusses CAR T-cell therapy

Associate Professor Michael Dickinson says CAR T-cell therapy is a 'revolutionary step forward'.

  • Acute lymphoblastic leukaemia
  • Chronic lymphocytic leukaemia
  • Hodgkin lymphoma
  • Interviews with experts
  • Myeloma
  • Non-Hodgkin lymphoma
  • Research
  • Treatments and side-effects
Read more
A/Prof. Dickinson enjoying gelato with his daughters in Melbourne

Leukaemia Foundation-funded research set to target lymphoma and paediatric blood cancers

  • Research
Read more
Illustration of a microscope, test tubes, and clipboard

Expert Series: Professor Miles Prince – the challenges, the treatments, the future of myeloma

Not only is Professor Miles Prince “a true believer in CAR T-cells”, he believes they may even have the potential to cure myeloma one day.

  • Interviews with experts
  • Myeloma
  • Research
Read more
Prof. Miles Prince presenting

Identifying high-risk smouldering myeloma to improve patient outcomes

Dr Melissa Cantley hopes that those who have this pre-canerous condition will be able to be tested to understand their risk of developing myeloma.

  • Myeloma
  • Research
Read more
Dr Melissa Cantley in the lab

Expert Series: Dr Rishi Kotecha on paediatric ALL

Dr Rishi Kotecha talks about the revolutionary treatments which are improving outcomes for babies and children with high-risk leukaemia.

  • Acute lymphoblastic leukaemia
  • Interviews with experts
  • Research
Read more
Dr Kotecha in the lab